ConductScience.org, home

Paper36929658

Metformin and thymoquinone co-treatment enhance 5-fluorouracil cytotoxicity by suppressing the PI3K/mTOR/HIF1α pathway and increasing oxidative stress in colon cancer cells.

Farrash WF and 12 others. Biofactors, 2023. Cited by 16 papers, by iCite.

Cite this record

ConductScience Library. Metformin and thymoquinone co-treatment enhance 5-fluorouracil cytotoxicity by suppressing the PI3K/mTOR/HIF1α pathway and increasing oxidative stress in colon cancer cells. Papers, record 36929658. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36929658

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Metformin and thymoquinone co-treatment enhance 5-fluorouracil cytotoxicity by suppressing the PI3K/mTOR/HIF1α pathway and increasing oxidative stress in colon cancer cells.
PubMed
Journal
Biofactors
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
16
iCite
Relative citation ratio, by iCite
2.27
iCite
Revised in PubMed
2026-01-27
PubMed

Authors13

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Farrash WFWesam F
2Aslam AAkhmed
3Almaimani RRiyad
4Minshawi FFaisal
5Almasmoum HHussain
6Alsaegh AAiman
7Iqbal MSMohammad S
8Tabassum AAisha
9Elzubier MEMohamed E
10El-Readi MZMahmoud Z
11Mahbub AAAmani A
12Idris SShakir
13Refaat BBassemhttps://orcid.org/0000-0003-4267-1016

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Colonic NeoplasmsMajor topic
FluorouracilMajor topic
MetforminMajor topic
Humans
Apoptosis
bcl-2-Associated X Protein
Caspase 3
Cell Line, Tumor
Cell Proliferation
Cytochromes
Oxidative Stress
Phosphatidylinositol 3-Kinases
Proliferating Cell Nuclear Antigen
Proto-Oncogene Proteins c-akt
Survivin
TOR Serine-Threonine Kinases
Hypoxia-Inducible Factor 1, alpha Subunit
Benzoquinones

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
IFP22UQU4320045DSR101The Deputyship for Research & Innovation, Ministry of Education in Saudi ArabiaPubMed

Source PubMed

Download CSV of grants

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.

PMIDTitleJournalYearIn PapersSource
42396351
Irisin Potentiates 5-fluorouracil Cytotoxicity in HT-29 Colon Cancer Cells through Enhanced Apoptosis and Transcriptional Modulation of Adenosine Monophosphate-activated Protein Kinase/Mammalian Target of Rapamycin Signaling.
Int J Appl Basic Med Res2026https://conductscience.org/library/papers/42396351PubMed
42389271Pharmacological mechanisms and clinical impacts of antidiabetic drugs on colorectal cancer risk: a systematic review.Front Pharmacol2026https://conductscience.org/library/papers/42389271PubMed
41002741Diagnostic and Therapeutic Value of the Exercise-Induced Myokine Irisin in Cancer Biology: A Comprehensive Review.Diseases2025https://conductscience.org/library/papers/41002741PubMed
40299210Increased protein expression of interleukin-10 and its signalling molecules in colon cancer progression: potential prognostic and therapeutic targets.Discov Oncol2025https://conductscience.org/library/papers/40299210PubMed
40264514Metformin Enhances the Chemosensitivity of Gastric Cancer to Cisplatin by Downregulating Nrf2 Level.Anal Cell Pathol (Amst)2025https://conductscience.org/library/papers/40264514PubMed
40059278Exploring potential additive effects of 5-fluorouracil, thymoquinone, and coenzyme Q10 triple therapy on colon cancer cells in relation to glycolysis and redox status modulation.J Egypt Natl Canc Inst2025https://conductscience.org/library/papers/40059278PubMed
39839894Poorly controlled type II diabetes mellitus significantly enhances postoperative chemoresistance in patients with stage III colon cancer.World J Gastroenterol2025https://conductscience.org/library/papers/39839894PubMed
39405607Role of glucose metabolic reprogramming in colorectal cancer progression and drug resistance.Transl Oncol2024https://conductscience.org/library/papers/39405607PubMed
39337420Effect of Sodium-Glucose Co-Transporter 2 Inhibitors Combined with Metformin on Pancreatic Cancer Cell Lines.Int J Mol Sci2024https://conductscience.org/library/papers/39337420PubMed
39309188Novel Strategies for Tumor Treatment: Harnessing ROS-Inducing Active Ingredients from Traditional Chinese Medicine Through Multifunctional Nanoformulations.Int J Nanomedicine2024https://conductscience.org/library/papers/39309188PubMed
38791419Additive Cytotoxic and Colony-Formation Inhibitory Effects of Aspirin and Metformin on PI3KCA-Mutant Colorectal Cancer Cells.Int J Mol Sci2024https://conductscience.org/library/papers/38791419PubMed
38248312Thymoquinone: A Promising Therapeutic Agent for the Treatment of Colorectal Cancer.Curr Issues Mol Biol2023https://conductscience.org/library/papers/38248312PubMed
38087345Potential anticancer properties and mechanisms of thymoquinone in colorectal cancer.Cancer Cell Int2023https://conductscience.org/library/papers/38087345PubMed

Download CSV of cited by

Genes13

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36929658

GET https://conductscience.org/api/papers/v1/36929658/authors